The article discusses how human rights should take precedence over intellectual property rights when it comes to access to medicines. Pharmaceutical companies claim rights to their medical discoveries, but human rights advocates argue that everyone should have access to essential medicines. Strong intellectual property protections have made medicines less accessible globally. The article suggests using advocacy and law reform to ensure access to medicines for all.